CytoMed Therapeutics Limited Proportion Of Voting Power Held In Associate
CytoMed Therapeutics Limited (GDTC) reported Proportion Of Voting Power Held In Associate of 20.00% for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:ProportionOfVotingPowerHeldInAssociate · last filed 2026-03-31
| Period end | Proportion Of Voting Power Held In Associate 12 month |
|---|---|
| 2025-12-31 | 20.00% 20-F · filed 2026-03-31 |
| 2024-12-31 | 20.00% 20-F · filed 2025-04-28 |
| 2023-12-31 | 20.00% 20-F · filed 2024-04-22 |
| 2022-12-31 | 20.00% 20-F · filed 2023-05-01 |